A Phase II study to evaluate the safety and efficacy of Terguride for the treatment of fibrosis in patients with systemic sclerosis
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Terguride (Primary)
- Indications Fibrosis; Systemic scleroderma
- Focus Biomarker; Proof of concept; Therapeutic Use
- 31 Jan 2017 New trial record